Metabolite Gene Integration via Bayesian Scoring
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Metabolomics is limited by ambiguous metabolite identifications and incomplete/inaccurate genome-based predictions of enzyme activities, leading to a poor understanding of metabolism, particularly in microbial systems.
Innovation Solution
The Metabolite Annotation and Gene Integration (MAGI) system, which uses a Bayesian-like method to associate metabolites with genes by scoring probabilistic relationships through liquid chromatography mass spectrometry data, chemical similarity networks, and homology searches, thereby improving metabolite identification and gene annotation accuracy.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If genome-based predictions are used to annotate enzyme activities, then gene annotations can be obtained, but the annotations are incomplete and inaccurate
Solution Approach 1:
The patent combines metabolomics data with genomics data through a Bayesian framework. The system integrates experimental metabolite measurements with genomic predictions to produce joint metabolite-gene associations, thereby merging two data sources to overcome the limitations of using either alone and improving both accuracy and completeness of gene annotations
Solution Approach 2:
The patent introduces a Bayesian statistical framework as an intermediary that connects metabolomics and genomics data. This framework computes joint associations between metabolites and genes by integrating evidence from both data types, serving as a mediator that transforms separate incomplete data sources into comprehensive gene annotations
2Measurement precision
If metabolomics is used to identify metabolites, then direct measures of metabolic activities are obtained, but metabolite identifications are ambiguous
Solution Approach 1:
The patent merges metabolomics data with genomics data through Bayesian integration. By combining experimental metabolite measurements with genomic context and pathway information, the system disambiguates metabolite identifications that would be ambiguous when using metabolomics data alone
Solution Approach 2:
The system uses feedback from genomic data to refine metabolite identifications. The Bayesian framework incorporates genomic evidence as feedback that adjusts the probability of metabolite identifications, allowing the system to resolve ambiguities by considering whether identified metabolites are consistent with the organism's genetic capacity
3Reliability
If traditional metabolomics and genomics are used separately, then individual data types can be analyzed, but the understanding of metabolism is limited
Solution Approach 1:
The patent merges metabolomics and genomics analyses into a unified Bayesian framework. This integration allows the system to leverage complementary information from both data types, producing more reliable metabolic understanding than either approach could achieve separately, while managing complexity through probabilistic computation
Data Source
AI summary
Disclosed herein are systems and methods for associating metabolites with genes. In some embodiments, after potential metabolites are identified based on spectroscopy data of the content of an organism, possible reactions capable of producing the potential metabolites are determined. The possible reactions are compared to gene sequences in a database, and an association score for the likelihood that a gene sequence is related to the potential metabolites is calculated.